The Role of IGF-1R in Pediatric Malignancies-Reference-Cited by-同舟云学术

The Role of IGF-1R in Pediatric Malignancies

Published:2009-01-01 Issue:1 Volume:14 Page:83-91
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Kim Su Young¹,Toretsky Jeffrey A.²,Scher Daniel²,Helman Lee J.¹

Affiliation:

1. a Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA

2. b Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, USA

Abstract

Learning Objectives Evaluate the components that make up the insulin-like growth factor family. Differentiate between different strategies to modulate IGF-1R. Determine when to utilize the rationale for therapeutic targeting of IGF-1R in childhood malignancies. This article is available for continuing medical education credit at CME.TheOncologist.com.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2008-0189

Reference70 articles.

1. Insulin-like growth factors and neoplasia;Pollak;Nat Rev Cancer,2004

2. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms;Calle;Nat Rev Cancer,2004

3. Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: A preliminary report;Shevah;Growth Horm IGF Res,2007

4. The role of circulating IGF-I: Lessons from human and animal models;Yakar;Endocrine,2002

5. IGF2: Epigenetic regulation and role in development and disease;Chao;Cytokine Growth Factor Rev,2008

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern treatment strategies in pediatric oncology and hematology;Discover Oncology;2023-06-14

2. The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models;Clinical Cancer Research;2022-11-02

3. Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine;International Journal of Molecular Sciences;2022-10-04

4. MiR-647 inhibits proliferation and improves apoptosis in cisplatin-treated non-small cell lung cancer via down-regulating IGF2 expression;ScienceAsia;2022

5. An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth;Journal of Cancer;2022